Skip to main content

Navigation group

Type at least 3 characters
551 articles

Articles

Original Research

Published on 20 Jan 2021

Impact of Implementing CYP2C19 Genotype-Guided Antiplatelet Therapy on P2Y12 Inhibitor Selection and Clinical Outcomes in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention: A Real-World Study in China

in Pharmacogenetics and Pharmacogenomics

  • Yi Zhang
  • Xiu-Jin Shi
  • Wen-Xing Peng
  • Jia-Lun Han
  • Bai-Di Lin
  • Ru Zhang
  • Yun-Nan Zhang
  • Jia-Lin Yan
  • Juan-Juan Wei
  • Yi-Fan Wang
Impact of Implementing CYP2C19 Genotype-Guided Antiplatelet Therapy on P2Y12 Inhibitor Selection and Clinical Outcomes in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention: A Real-World Study in China
Frontiers in Pharmacology
doi 10.3389/fphar.2020.582929
  • 6,156 views
  • 19 citations